Roopa Industries Ltd Sustainability Reports
Roopa Industries Limited manufactures active pharmaceutical ingredients (APIs), bulk drugs, drug intermediates, and nutraceuticals. Its product portfolio includes triphenyl phosphine, fluconazole, sildenafil citrate, and glucosamine salts.
Sector: Manufacturing
Country: India
Exchange: Bombay Stock Exchange
LEI: 8945003JY5N7ISQS8K24
FIGI: BBG001S82L28
3 reports from 2016 to 2024